Intra-nuclear trafficking of the BLM helicase to DNA damage-induced foci is regulated by SUMO modification.

The Bloom syndrome gene, BLM, encodes a RecQ DNA helicase that when absent from the cell results in genomic instability and cancer predisposition. We show here that BLM is a substrate for small ubiquitin-like modifier (SUMO) modification, with lysines at K317, K331, K334 and K347 being preferred sites of modification. Unlike normal BLM, a double mutant BLM protein with lysine to arginine substitutions at residues 317 and 331 was not modified by SUMO, and it failed to localize efficiently to the PML nuclear bodies. Rather, double mutant BLM protein induced the formation of DNA damage-induced foci (DDI) that contained BRCA1 protein and phosphorylated histone H2AX. Double mutant BLM only partially complemented the genomic instability phenotypes of Bloom syndrome cells as assessed by sister-chromatid exchange and micronuclei formation assays. These results constitute evidence that BLM is a DNA damage sensor that signals the formation of DDI, and they establish SUMO modification as a negative regulator of BLM's signaling function.

[1]  A. Prescott,et al.  p14 Arf Promotes Small Ubiquitin-like Modifier Conjugation of Werners Helicase* , 2004, Journal of Biological Chemistry.

[2]  R. Hansen,et al.  ATR and ATM-Dependent Movement of BLM Helicase during Replication Stress Ensures Optimal ATM Activation and 53BP1 Focus Formation , 2004, Cell cycle.

[3]  C. Harris,et al.  Functional interaction between BLM helicase and 53BP1 in a Chk1-mediated pathway during S-phase arrest , 2004, The Journal of cell biology.

[4]  F. Rosselli,et al.  BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks , 2004, The EMBO journal.

[5]  S. Müller,et al.  SUMO: a regulator of gene expression and genome integrity , 2004, Oncogene.

[6]  I. Hickson,et al.  Phosphorylation of the Bloom's Syndrome Helicase and Its Role in Recovery from S-Phase Arrest , 2004, Molecular and Cellular Biology.

[7]  Ian D. Hickson,et al.  The Bloom's syndrome helicase suppresses crossing over during homologous recombination , 2003, Nature.

[8]  P. Pandolfi,et al.  Role of PML and the PML-nuclear body in the control of programmed cell death , 2003, Oncogene.

[9]  F. Melchior,et al.  SUMO: ligases, isopeptidases and nuclear pores. , 2003, Trends in biochemical sciences.

[10]  C. Bishop,et al.  A novel ubiquitin ligase is deficient in Fanconi anemia , 2003, Nature Genetics.

[11]  J. Campisi,et al.  Bloom syndrome cells undergo p53-dependent apoptosis and delayed assembly of BRCA1 and NBS1 repair complexes at stalled replication forks , 2003, The Journal of cell biology.

[12]  J. Petrini,et al.  The cellular response to DNA double-strand breaks: defining the sensors and mediators. , 2003, Trends in cell biology.

[13]  A. Dejean,et al.  Nuclear and unclear functions of SUMO , 2003, Nature Reviews Molecular Cell Biology.

[14]  C. Boutell,et al.  PML Residue Lysine 160 Is Required for the Degradation of PML Induced by Herpes Simplex Virus Type 1 Regulatory Protein ICP0 , 2003, Journal of Virology.

[15]  David L. Spector,et al.  Nuclear speckles: a model for nuclear organelles , 2003, Nature Reviews Molecular Cell Biology.

[16]  Alan D. D'Andrea Fanconi anemia , 2003, Current Biology.

[17]  T. Bickle,et al.  Characterization and mutational analysis of the RecQ core of the bloom syndrome protein. , 2003, Journal of Molecular Biology.

[18]  David C Schwartz,et al.  A superfamily of protein tags: ubiquitin, SUMO and related modifiers. , 2003, Trends in biochemical sciences.

[19]  Weidong Wang,et al.  A Multiprotein Nuclear Complex Connects Fanconi Anemia and Bloom Syndrome , 2003, Molecular and Cellular Biology.

[20]  J. Shay,et al.  BLM helicase‐dependent transport of p53 to sites of stalled DNA replication forks modulates homologous recombination , 2003, The EMBO journal.

[21]  I. Hickson RecQ helicases: caretakers of the genome , 2003, Nature Reviews Cancer.

[22]  A. D’Andrea,et al.  S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. , 2002, Blood.

[23]  N. Maizels,et al.  G4 DNA unwinding by BLM and Sgs1p: substrate specificity and substrate-specific inhibition. , 2002, Nucleic acids research.

[24]  N. Ellis,et al.  Functional Link between BLM Defective in Bloom's Syndrome and the Ataxia-telangiectasia-mutated Protein, ATM* , 2002, The Journal of Biological Chemistry.

[25]  O. Jänne,et al.  PIAS Proteins Modulate Transcription Factors by Functioning as SUMO-1 Ligases , 2002, Molecular and Cellular Biology.

[26]  Michel C. Nussenzweig,et al.  Genomic Instability in Mice Lacking Histone H2AX , 2002, Science.

[27]  A. Franchitto,et al.  Bloom's syndrome protein is required for correct relocalization of RAD50/MRE11/NBS1 complex after replication fork arrest , 2002, The Journal of cell biology.

[28]  A. Dejean,et al.  The Nucleoporin RanBP2 Has SUMO1 E3 Ligase Activity , 2002, Cell.

[29]  Erica S. Johnson,et al.  An E3-like Factor that Promotes SUMO Conjugation to the Yeast Septins , 2001, Cell.

[30]  M. Tatham,et al.  Polymeric Chains of SUMO-2 and SUMO-3 Are Conjugated to Protein Substrates by SAE1/SAE2 and Ubc9* , 2001, The Journal of Biological Chemistry.

[31]  Ian D. Hickson,et al.  The Bloom's and Werner's syndrome proteins are DNA structure-specific helicases , 2001, Nucleic Acids Res..

[32]  Paul Freemont,et al.  Role of Promyelocytic Leukemia (Pml) Sumolation in Nuclear Body Formation, 11s Proteasome Recruitment, and as2O3-Induced Pml or Pml/Retinoic Acid Receptor α Degradation , 2001, The Journal of experimental medicine.

[33]  Min Wang,et al.  The Small Ubiquitin-like Modifier-1 (SUMO-1) Consensus Sequence Mediates Ubc9 Binding and Is Essential for SUMO-1 Modification* , 2001, The Journal of Biological Chemistry.

[34]  P. Pandolfi,et al.  Evidence for BLM and Topoisomerase IIIα interaction in genomic stability , 2001 .

[35]  R. Hay,et al.  SUMO-1 Conjugation in Vivo Requires Both a Consensus Modification Motif and Nuclear Targeting* , 2001, The Journal of Biological Chemistry.

[36]  N. Ellis,et al.  Regulation and Localization of the Bloom Syndrome Protein in Response to DNA Damage , 2001, The Journal of cell biology.

[37]  S. Ganesan,et al.  Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. , 2001, Molecular cell.

[38]  N. Ellis,et al.  BLM, the Bloom’s syndrome protein, varies during the cell cycle in its amount, distribution, and co-localization with other nuclear proteins , 2001, Cytogenetic and Genome Research.

[39]  N. Ellis,et al.  Binding and melting of D-loops by the Bloom syndrome helicase. , 2000, Biochemistry.

[40]  V. Yamazaki,et al.  A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage , 2000, Current Biology.

[41]  Y. Furuichi,et al.  Covalent Modification of the Werner's Syndrome Gene Product with the Ubiquitin-related Protein, SUMO-1* , 2000, The Journal of Biological Chemistry.

[42]  S. West,et al.  The Bloom's syndrome gene product promotes branch migration of holliday junctions. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[43]  C. Jaulin,et al.  Cell cycle regulation of the endogenous wild type Bloom's syndrome DNA helicase , 2000, Oncogene.

[44]  L. Guarente,et al.  Nijmegen breakage syndrome disease protein and MRE11 at PML nuclear bodies and meiotic telomeres. , 2000, Cancer research.

[45]  P. Pandolfi,et al.  Role of SUMO-1-modified PML in nuclear body formation. , 2000, Blood.

[46]  S. Elledge,et al.  BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. , 2000, Genes & development.

[47]  P. Pandolfi,et al.  A role for PML and the nuclear body in genomic stability , 1999, Oncogene.

[48]  N. Ellis,et al.  Purification of overexpressed hexahistidine-tagged BLM N431 as oligomeric complexes. , 1999, Protein expression and purification.

[49]  N. Ellis,et al.  Transfection of BLM into cultured bloom syndrome cells reduces the sister-chromatid exchange rate toward normal. , 1999, American journal of human genetics.

[50]  E. Yeh,et al.  Pml Is Critical for Nd10 Formation and Recruits the Pml-Interacting Protein Daxx to This Nuclear Structure When Modified by Sumo-1 , 1999, The Journal of cell biology.

[51]  A. Dejean,et al.  The PML nuclear bodies: actors or extras? , 1999, Current opinion in genetics & development.

[52]  A. Dejean,et al.  Viral Immediate-Early Proteins Abrogate the Modification by SUMO-1 of PML and Sp100 Proteins, Correlating with Nuclear Body Disruption , 1999, Journal of Virology.

[53]  J. Noonan,et al.  The DNA helicase activity of BLM is necessary for the correction of the genomic instability of bloom syndrome cells. , 1999, Molecular biology of the cell.

[54]  S. Carr,et al.  Examination of micro-tip reversed-phase liquid chromatographic extraction of peptide pools for mass spectrometric analysis. , 1998, Journal of chromatography. A.

[55]  N. Maizels,et al.  The Bloom’s Syndrome Helicase Unwinds G4 DNA* , 1998, The Journal of Biological Chemistry.

[56]  P. Freemont,et al.  The Disruption of ND10 during Herpes Simplex Virus Infection Correlates with the Vmw110- and Proteasome-Dependent Loss of Several PML Isoforms , 1998, Journal of Virology.

[57]  R. Hay,et al.  SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. , 1998, Molecular cell.

[58]  I. Hickson,et al.  The Bloom’s Syndrome Gene Product Is a 3′-5′ DNA Helicase* , 1997, The Journal of Biological Chemistry.

[59]  K. Kinzler,et al.  The Genetic Basis of Human Cancer , 1997 .

[60]  Ralph Scully,et al.  Dynamic Changes of BRCA1 Subnuclear Location and Phosphorylation State Are Initiated by DNA Damage , 1997, Cell.

[61]  G. Blobel,et al.  A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex , 1996, The Journal of cell biology.

[62]  J. Petrini,et al.  DNA replication-dependent nuclear dynamics of the Mre11 complex. , 2003, Molecular cancer research : MCR.

[63]  P. Pandolfi,et al.  Evidence for BLM and Topoisomerase IIIalpha interaction in genomic stability. , 2001, Human molecular genetics.

[64]  N. Ellis,et al.  DNA helicases, genomic instability, and human genetic disease. , 2000, Annual review of genomics and human genetics.

[65]  V. Michels,et al.  The Genetic Basis of Human Cancer , 1999 .